BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22344564)

  • 21. Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas.
    Weigle B; Ebner R; Temme A; Schwind S; Schmitz M; Kiessling A; Rieger MA; Schackert G; Schackert HK; Rieber EP
    Oncol Rep; 2005 Jan; 13(1):139-44. PubMed ID: 15583815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
    Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
    Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas.
    Ishiwata T; Teduka K; Yamamoto T; Kawahara K; Matsuda Y; Naito Z
    Oncol Rep; 2011 Jul; 26(1):91-9. PubMed ID: 21503585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
    Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
    J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
    Kong L; Li Q; Wang L; Liu Z; Sun T
    Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.
    Hagemann C; Anacker J; Gerngras S; Kühnel S; Said HM; Patel R; Kämmerer U; Vordermark D; Roosen K; Vince GH
    Oncol Rep; 2008 Aug; 20(2):301-8. PubMed ID: 18636190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoids induced t-PA synthesis by C6 glioma cells--role in tumoral haemorrhagic necrosis.
    Pernod G; Amalfitano G; Le Magueresse B; Berger F; Polack B; Kolodié L
    Thromb Haemost; 1996 Feb; 75(2):332-8. PubMed ID: 8815586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plexin-B1: a potential diagnostic biomarker for glioma and a future target for glioma immunotherapy.
    Zhang Y; Li Q; Zhuang R; Gao Z; Liu J; Li J; Yang A; Cheng G; Jin B
    J Neuroimmunol; 2012 Nov; 252(1-2):113-7. PubMed ID: 22939532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glioma stem cell signaling: therapeutic opportunities and challenges.
    Dietrich J; Diamond EL; Kesari S
    Expert Rev Anticancer Ther; 2010 May; 10(5):709-22. PubMed ID: 20470003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival.
    Werner JM; Kuhl S; Stavrinou P; Röhn G; Krischek B; Blau T; Goldbrunner R; Timmer M
    Anticancer Res; 2017 Dec; 37(12):6639-6648. PubMed ID: 29187439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein and mRNA levels of YKL-40 in high-grade glioma.
    Kazakova MH; Staneva DN; Koev IG; Staikov DG; Mateva N; Timonov PT; Miloshev GA; Sarafian VS
    Folia Biol (Praha); 2014; 60(6):261-7. PubMed ID: 25629266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified and modified procedure to culture brain glioma stem cells from clinical specimens.
    Qiu B; Zhang D; Tao J; Wu A; Wang Y
    Oncol Lett; 2012 Jan; 3(1):50-54. PubMed ID: 22740855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target.
    Chen S; Zhao H; Deng J; Liao P; Xu Z; Cheng Y
    J Cell Biochem; 2013 Dec; 114(12):2795-808. PubMed ID: 23836528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of okadaic-acid-induced genes by mRNA differential display in glioma cells.
    Chin LS; Singh SK; Wang Q; Murray SF
    J Biomed Sci; 2000; 7(2):152-9. PubMed ID: 10754390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Glial brain tumor stem cells].
    Borisov KE; Sakaeva DD
    Arkh Patol; 2013; 75(2):43-52. PubMed ID: 24006765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of versican isoforms in brain tumors.
    Paulus W; Baur I; Dours-Zimmermann MT; Zimmermann DR
    J Neuropathol Exp Neurol; 1996 May; 55(5):528-33. PubMed ID: 8627343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboxane synthase regulates the migratory phenotype of human glioma cells.
    Giese A; Hagel C; Kim EL; Zapf S; Djawaheri J; Berens ME; Westphal M
    Neuro Oncol; 1999 Jan; 1(1):3-13. PubMed ID: 11550298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunobiology and immunotherapeutic targeting of glioma stem cells.
    Madany M; Thomas TM; Edwards L; Yu JS
    Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
    Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
    J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.